Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151).

Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151). Transplant Proc. 1989 Feb; 21(1 Pt 1):293-5.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.